Inventing the Future with Synthetic Biology

GenomeWeb
360Dx

Inventing the Future with Synthetic Biology

Aug 19, 2008

Forbes features Ginkgo BioWorks, a synthetic biology company started by MIT's Tom Knight and three of his PhD students, including Reshma Shetty.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Biocept Shares Skyrocket on Commercial Launch of Lung Cancer Liquid Biopsy Test
Personalis, FLX Bio Sign Research Agreement for Use of Universal Cancer Immunogenomics Platform
Top Five Articles on GenomeWeb Last Week: Illumina, MGI, RNA in Plasma, and More
In Brief This Week: Grail, Stilla Technologies, SpeeDx, and More
Host, Bacterial Genes Influence Meningitis Infection Susceptibility, Severity
Curetis Posts 45 Percent Increase in Q1 Revenues

The Scan

Subcommittee Calls for More Funding

A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.

Model of Discovery

University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.

Limit of Relevance

Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.

This Week in PLOS

In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.

Menu